LIFEVANTAGE CORP NAMES TERRENCE MOOREHEAD PRESIDENT AND CEO STARTING AUGUST 5, 2026

Written by Emily J. Thompson, Senior Investment Analyst

Source: moomoo

Updated: Apr 16 2026

0mins

LFVN+6.37%

Should l Buy LFVN?

Source: moomoo

Leadership Change: LifeVantage Corporation has appointed Terrence Moorehead as the new President and CEO.
Effective Date: The appointment will take effect on August 5, 2026.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy LFVN?" and start using high-conviction signals backed by rigorous historical data.

Analyst Views on LFVN

Wall Street analysts forecast LFVN stock price to rise

1 Analyst Rating

1 Buy

0 Hold

0 Sell

Moderate Buy

Current: 5.020

Low

12.00

Averages

12.00

High

12.00

Current: 5.020

Low

12.00

Averages

12.00

High

12.00

Lake Street

Buy

Hold

downgrade

2026-05-07

New

Reason

Lake Street

Price Target

AI Analysis

2026-05-07

New

downgrade

Buy

Hold

Reason

Lake Street downgraded LifeVantage to Hold from Buy with a $5 price target. Q3 results came in below expectations and while management maintained its prior FY26 guidance framework, it now expects results to come in near the low end of the range, the analyst tells investors. The firm, which is lowering estimates below the company's updated outlook, says that while valuation "remains inexpensive," it believes revenue headwinds are likely to persist over at least the next two quarters, limiting upside potential.

Lake Street

Buy

downgrade

$12 -> $5

2026-02-05

Reason

Lake Street

Price Target

$12 -> $5

2026-02-05

downgrade

Buy

Reason

Lake Street lowered the firm's price target on LifeVantage to $5 from $12 and keeps a Buy rating on the shares after the company's second quarter results and updated guidance were weaker than expected. With shares trading off 25% after hours, the firm believes valuation has likely troughed and thinks "there is a path for the multiple to work higher over time" if the company can execute against its revised FY26 guidance, the analyst tells investors.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for LFVN

Unlock Now

About LFVN

LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

LifeVantage Q3 Fiscal 2026 Earnings Call Insights and Outlook

3 days agoseekingalpha

Declining Financial Performance: LifeVantage reported net revenue of $43.7 million for Q3, a 25.2% year-over-year decline primarily driven by decreased sales of the MindBody GLP-1 System, although LoveBiome sales partially offset this impact, indicating pressure in a competitive market environment.
CEO Appointment and Leadership Change: The company announced that Terrence Moorehead will take over as CEO in August, bringing over 30 years of leadership experience in direct selling, aimed at enhancing performance through stability and new strategies, especially as current results fall short of expectations.
Launch of VIP Bonus Program: LifeVantage introduced its first-ever 12-month volume growth incentive program for consultants, designed to reward sales growth and elevate consultant engagement and leadership, which is seen as a potential game changer for future sales performance.
E-commerce Platform Upgrade Plans: The company is investing in upgrading its e-commerce platform, with plans to launch Shopify later this year, which is expected to significantly enhance the online experience for both customers and consultants, thereby strengthening market competitiveness and driving future sales growth.

LifeVantage (LFVN) Q3 2026 Earnings Transcript

3 days agoNASDAQ.COM

LifeVantage Q3 Earnings Miss Expectations

3 days agoseekingalpha

Disappointing Earnings: LifeVantage reported a Q3 non-GAAP EPS of $0.12, missing expectations by $0.04, indicating a decline in profitability that may undermine investor confidence.
Significant Revenue Decline: The company’s Q3 revenue of $43.7 million represents a 25.2% year-over-year decrease, falling short of the anticipated $44.0 million, reflecting weakened market demand and increased competitive pressures.
Adjusted FY 2026 Guidance: LifeVantage anticipates that its FY 2026 revenue, adjusted EBITDA, and adjusted earnings per share will be close to the lower end of its previously issued guidance, highlighting growing challenges and uncertainties facing the company.
Tax Rate Expectations: The company expects a full-year tax rate of approximately 18% to 20%, which will impact future financial performance, particularly in the context of its international expansion and new product launches.

LifeVantage Appoints New CEO Terrence Moorehead Effective August 2026

Apr 16 2026seekingalpha

Executive Appointment: LifeVantage has appointed Terrence Moorehead as the new President and CEO, effective August 5, 2026, marking a significant leadership change aimed at driving future growth and innovation within the company.
Succession Plan: Moorehead will succeed Steve Fife, who is set to retire on April 30, with Director Michael Beindorff serving as interim CEO during the transition, ensuring stable operations throughout this period.
Board Membership: New CEO Moorehead will also join the LifeVantage board, a move that not only strengthens corporate governance but also provides robust leadership support for future strategic decisions.
Market Reaction: This executive change may impact investor confidence, particularly as the company faces market challenges from GLP-1 hormone drugs and the integration of LoveBiome, with the future leadership direction likely to have profound implications for company performance.

LifeVantage Appoints New CEO Terrence Moorehead

Apr 16 2026Newsfilter

New CEO Appointment: LifeVantage has appointed Terrence Moorehead as the new President and CEO, effective August 5, 2026, bringing over 25 years of leadership experience that is expected to revitalize the brand and accelerate customer growth.
Retirement of Former CEO: Current CEO Steve Fife will retire on April 30, 2026, with Moorehead's appointment aimed at ensuring leadership stability during the transition, as Fife has significantly contributed to the company's transformation and financial health over the past nine years.
Transition Leadership Team: Prior to Moorehead's start, the Board has appointed Michael Beindorff as Interim CEO to ensure continuity, with the interim team comprising experienced executives capable of effectively managing the company's operations during this period.
Strategic Growth Potential: Moorehead expressed that LifeVantage's science-backed products and passionate consultant community create a strong foundation for future growth, with expectations to further enhance brand positioning and drive sustainable growth to deliver shareholder value.